Alzheimer Disease: all 3,765 studies

Page 14 of 38. Open to participants first (881), then studies with results posted, then the rest; newest registration first within each.

• Care Ecosystem: Navigating Patients and Families Through Stages of CareCompletedNCT02213458Not applicableResults posted
• Magnesium L-Threonate for the Enhancement of Learning and Memory in People With DementiaCompletedNCT02210286Not applicableResults posted
• A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type DementiaCompletedNCT02185053Phase 2Results posted
• A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's DiseaseCompletedNCT02167256Phase 2Results posted
• Promoting Adaptive Neuroplasticity in Mild Cognitive ImpairmentCompletedNCT02155946Not applicableResults posted
• Treatment of Psychosis and Agitation in Alzheimer's DiseaseCompletedNCT02129348Phase 2Results posted
• Florbetapir Calibration to the Centiloid ScaleCompletedNCT02120664Phase 1Results posted
• The Feasibility of Florbetapir Quantitation in EuropeCompletedNCT02107599Phase 4Results posted
• Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's DiseaseCompletedNCT02097056Phase 4Results posted
• Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's DiseaseCompletedNCT02087865Phase 4Results posted
• Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's DiseaseTerminatedNCT02080364Phase 3Results posted
• Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)CompletedNCT02079909Phase 2Results posted
• Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's DiseaseCompletedNCT02079246Phase 3Results posted
• Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318)CompletedNCT02064920Phase 2Results posted
• Evaluation of Reader Training ProcessesCompletedNCT02051790Phase 4Results posted
• Imaging Characteristics of a Follow-up 18F-AV-1451 ScanTerminatedNCT02051764Phase 2Results posted
• A Study of Gantenerumab in Participants With Mild Alzheimer DiseaseCompletedNCT02051608Phase 3Results posted
• Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy AdultsCompletedNCT02051335Phase 1Results posted
• A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease PsychosisCompletedNCT02035553Phase 2Results posted
• Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD SubjectsCompletedNCT02016560Phase 2/3Results posted
• Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of TreatmentCompletedNCT02007291Results posted
• Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase InhibitorCompletedNCT02006654Phase 3Results posted
• Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With DonepezilCompletedNCT02006641Phase 3Results posted
• Levetiracetam for Alzheimer's Disease-Associated Network HyperexcitabilityCompletedNCT02002819Phase 2Results posted
• Alzheimer's Prevention Through ExerciseCompletedNCT02000583Not applicableResults posted
• A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Including a Placebo-Treated Non-Carrier CohortCompletedNCT01998841Phase 2Results posted
• Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative CareCompletedNCT01993836Phase 4Results posted
• A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired SubjectsCompletedNCT01992380Phase 1Results posted
• Intensive Instruction on the Use of AriceptCompletedNCT01972204Not applicableResults posted
• Effect of Insulin Sensitizer Metformin on AD BiomarkersCompletedNCT01965756Phase 2Results posted
• Enhancing Spatial Navigation Using Non-Invasive Brain StimulationCompletedNCT01958437Not applicableResults posted
• Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With DonepezilCompletedNCT01955161Phase 3Results posted
• Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)TerminatedNCT01953601Phase 3Results posted
• Olfactory Deficits and Donepezil Treatment in Cognitively Impaired ElderlyCompletedNCT01951118Phase 4Results posted
• 16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease PatientsCompletedNCT01948791Phase 4Results posted
• The Feasibility of Florbetapir QuantitationCompletedNCT01946243Phase 4Results posted
• Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its OnsetTerminatedNCT01931566Phase 3Results posted
• Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's TypeCompletedNCT01922258Phase 3Results posted
• Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus PlaceboTerminatedNCT01900665Phase 3Results posted
• The Effect of rTMS Treatment on Alzheimer's and Sleep QualityCompletedNCT01894620Not applicableResults posted
• Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.CompletedNCT01890343Phase 2Results posted
• Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive ImpairmentCompletedNCT01876823Phase 2/3Results posted
• A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's AgitationCompletedNCT01862640Phase 3Results posted
• Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012)TerminatedNCT01852110Phase 2Results posted
• A Study of LY3002813 in Participants With Alzheimer's DiseaseCompletedNCT01837641Phase 1Results posted
• Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot StudyCompletedNCT01834716Not applicableResults posted
• A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's DiseaseCompletedNCT01807026Phase 1Results posted
• Bexarotene Amyloid Treatment for Alzheimer's DiseaseCompletedNCT01782742Phase 2Results posted
• The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)CompletedNCT01767909Phase 2/3Results posted
• A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's DiseaseCompletedNCT01767311Phase 2Results posted
• A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseaseTerminatedNCT01766336Phase 2Results posted
• An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)TerminatedNCT01739348Phase 2/3Results posted
• Long-Term Study of IGIV, 10% in Alzheimer´s DiseaseTerminatedNCT01736579Phase 3Results posted
• Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseaseCompletedNCT01735630Phase 2Results posted
• A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's DiseaseCompletedNCT01734395Results posted
• Valproic Acid in Subjects With Intact Cognition - Proof of Concept StudyCompletedNCT01729598Early Phase 1Results posted
• A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With CrenezumabCompletedNCT01723826Phase 2Results posted
• Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On DonepezilTerminatedNCT01712074Phase 2Results posted
• Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive DeclineCompletedNCT01703702Phase 4Results posted
• Riluzole in Mild Alzheimer's DiseaseCompletedNCT01703117Phase 2Results posted
• Indiana University Dementia Screening TrialCompletedNCT01699503Not applicableResults posted
• Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) ImagesCompletedNCT01672827Phase 3Results posted
• A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)CompletedNCT01662882Phase 2/3Results posted
• A Study of Florbetapir (18F) in Japanese Healthy VolunteersCompletedNCT01660815Phase 1Results posted
• Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's DiseaseTerminatedNCT01626391Phase 2Results posted
• Efficacy and Safety of Filgrastim in Alzheimer's DiseaseCompletedNCT01617577Phase 1/2Results posted
• Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)CompletedNCT01614886Phase 3Results posted
• Venlafaxine for Depression in Alzheimer's Disease (DIADs-3)CompletedNCT01609348Not applicableResults posted
• ADvance DBS-f in Patients With Mild Probable Alzheimer's DiseaseCompletedNCT01608061Not applicableResults posted
• Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET)CompletedNCT01607476Phase 2Results posted
• Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)CompletedNCT01595646Phase 2Results posted
• Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's DementiaCompletedNCT01585272Phase 4Results posted
• Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's DiseaseCompletedNCT01584440Phase 2Results posted
• Conversations as a Means to Delay the Onset of Alzheimer's DiseaseCompletedNCT01571427Early Phase 1Results posted
• Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)CompletedNCT01565382Phase 3Results posted
• Evaluation of Physician Training Methods to Read Florbetapir-PET ScansCompletedNCT01565369Not applicableResults posted
• Evaluation of PET Scan Timing Relative to AV-45 Injection TimeCompletedNCT01565356Not applicableResults posted
• A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy VolunteersCompletedNCT01565343Phase 1Results posted
• A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy VolunteersCompletedNCT01565330Phase 1Results posted
• A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly VolunteersCompletedNCT01565291Early Phase 1Results posted
• A Study of 18F-AV-45 in Healthy VolunteersCompletedNCT01564706Phase 1Results posted
• Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's DiseaseTerminatedNCT01561430Phase 1/2Results posted
• A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's DiseaseCompletedNCT01561053Phase 2/3Results posted
• Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's DiseaseTerminatedNCT01560585Phase 1/2Results posted
• Seizure Activity in Alzheimer's DiseaseCompletedNCT01554683Not applicableResults posted
• Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET ScansCompletedNCT01550549Not applicableResults posted
• Phase 3 IGIV, 10% in Alzheimer´s DiseaseTerminatedNCT01524887Phase 3Results posted
• Clinical Evaluation of Florbetapir F 18 (18F-AV-45)CompletedNCT01518374Phase 2Results posted
• A Randomized SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's DiseaseCompletedNCT01513967Phase 1/2Results posted
• Effects of a Combined Transcranial Magnetic Stimulation (TMS) and Cognitive Training in Alzheimer PatientsCompletedNCT01504958Not applicableResults posted
• Resveratrol for Alzheimer's DiseaseCompletedNCT01504854Phase 2Results posted
• Effects of Transcranial Direct Current Stimulation on the Apathy of Alzheimer's DiseaseCompletedNCT01481558Phase 2Results posted
• Minocycline in Patients With Alzheimer's DiseaseCompletedNCT01463384Phase 2Results posted
• A Non-drug Methods Study in Participants With Alzheimer's DiseaseCompletedNCT01459016Phase 1Results posted
• Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's DiseaseCompletedNCT01453569Phase 2Results posted
• Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07CompletedNCT01447719Phase 3Results posted
• Endothelial Facilitation in Alzheimer's DiseaseCompletedNCT01439555Phase 2Results posted
• Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's TypeCompletedNCT01438060Phase 3Results posted
• Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.CompletedNCT01436045Phase 2Results posted
• Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IVCompletedNCT01434667Not applicableResults posted

← Alzheimer Disease overview